BACKGROUND: Congenital Zika virus (ZIKV) syndrome is a newly identified condition resulting from infection during pregnancy. We analyzed outcome data from a mother-infant cohort in Rio de Janeiro in order to assess whether clinical severity of maternal ZIKV infection was associated with maternal virus load, prior dengue antibodies, or abnormal pregnancy/infant outcomes. METHODS: A clinical severity assessment tool was developed based on duration of fever, severity of rash, multisystem involvement, and duration of symptoms during ZIKV infection. ZIKV-RNA load was quantified by polymerase chain reaction (PCR) cycles in blood/ urine. Dengue immunoglobulin G (IgG) antibodies were measured at baseline. Adverse outcomes were defined as fetal loss or a live infant with grossly abnormal clinical or brain imaging findings. Regression models were used to study potential associations. RESULTS: 131 ZIKV-PCR positive pregnant women were scored for clinical disease severity, 6 (4.6%) had mild disease, 98 (74.8%) had moderate disease, and 27 (20.6%) severe manifestations of ZIKV infection. There were 58 (46.4%) abnormal outcomes with 9 fetal losses (7.2%) in 125 pregnancies. No associations were found between: disease severity and abnormal outcomes (P = .961; odds ratio [OR]: 1.00; 95% confidence interval [CI]: 0.796-1.270); disease severity and viral load (P = .994); viral load and adverse outcomes (P = .667; OR: 1.02; 95% CI: 0.922-1.135); or existence of prior dengue antibodies (88% subjects) with severity score, ZIKV-RNA load or adverse outcomes (P = .667; OR: 0.78; 95% CI: 0.255-2.397). CONCLUSIONS: Congenital ZIKV syndrome does not appear to be associated with maternal disease severity, ZIKV-RNA load at time of infection or existence of prior dengue antibodies.
BACKGROUND: Congenital Zika virus (ZIKV) syndrome is a newly identified condition resulting from infection during pregnancy. We analyzed outcome data from a mother-infant cohort in Rio de Janeiro in order to assess whether clinical severity of maternal ZIKV infection was associated with maternal virus load, prior dengue antibodies, or abnormal pregnancy/infant outcomes. METHODS: A clinical severity assessment tool was developed based on duration of fever, severity of rash, multisystem involvement, and duration of symptoms during ZIKV infection. ZIKV-RNA load was quantified by polymerase chain reaction (PCR) cycles in blood/ urine. Dengue immunoglobulin G (IgG) antibodies were measured at baseline. Adverse outcomes were defined as fetal loss or a live infant with grossly abnormal clinical or brain imaging findings. Regression models were used to study potential associations. RESULTS: 131 ZIKV-PCR positive pregnant women were scored for clinical disease severity, 6 (4.6%) had mild disease, 98 (74.8%) had moderate disease, and 27 (20.6%) severe manifestations of ZIKV infection. There were 58 (46.4%) abnormal outcomes with 9 fetal losses (7.2%) in 125 pregnancies. No associations were found between: disease severity and abnormal outcomes (P = .961; odds ratio [OR]: 1.00; 95% confidence interval [CI]: 0.796-1.270); disease severity and viral load (P = .994); viral load and adverse outcomes (P = .667; OR: 1.02; 95% CI: 0.922-1.135); or existence of prior dengue antibodies (88% subjects) with severity score, ZIKV-RNA load or adverse outcomes (P = .667; OR: 0.78; 95% CI: 0.255-2.397). CONCLUSIONS: Congenital ZIKV syndrome does not appear to be associated with maternal disease severity, ZIKV-RNA load at time of infection or existence of prior dengue antibodies.
Authors: Jeffrey M Denney; Edward L Nelson; Pathik D Wadhwa; Thaddeus P Waters; Leny Mathew; Esther K Chung; Robert L Goldenberg; Jennifer F Culhane Journal: Cytokine Date: 2010-11-30 Impact factor: 3.861
Authors: L M Mofenson; J S Lambert; E R Stiehm; J Bethel; W A Meyer; J Whitehouse; J Moye; P Reichelderfer; D R Harris; M G Fowler; B J Mathieson; G J Nemo Journal: N Engl J Med Date: 1999-08-05 Impact factor: 91.245
Authors: Margaret A Honein; April L Dawson; Emily E Petersen; Abbey M Jones; Ellen H Lee; Mahsa M Yazdy; Nina Ahmad; Jennifer Macdonald; Nicole Evert; Andrea Bingham; Sascha R Ellington; Carrie K Shapiro-Mendoza; Titilope Oduyebo; Anne D Fine; Catherine M Brown; Jamie N Sommer; Jyoti Gupta; Philip Cavicchia; Sally Slavinski; Jennifer L White; S Michele Owen; Lyle R Petersen; Coleen Boyle; Dana Meaney-Delman; Denise J Jamieson Journal: JAMA Date: 2017-01-03 Impact factor: 56.272
Authors: Patrícia Brasil; José P Pereira; M Elisabeth Moreira; Rita M Ribeiro Nogueira; Luana Damasceno; Mayumi Wakimoto; Renata S Rabello; Stephanie G Valderramos; Umme-Aiman Halai; Tania S Salles; Andrea A Zin; Dafne Horovitz; Pedro Daltro; Marcia Boechat; Claudia Raja Gabaglia; Patrícia Carvalho de Sequeira; José H Pilotto; Raquel Medialdea-Carrera; Denise Cotrim da Cunha; Liege M Abreu de Carvalho; Marcos Pone; André Machado Siqueira; Guilherme A Calvet; Ana E Rodrigues Baião; Elizabeth S Neves; Paulo R Nassar de Carvalho; Renata H Hasue; Peter B Marschik; Christa Einspieler; Carla Janzen; James D Cherry; Ana M Bispo de Filippis; Karin Nielsen-Saines Journal: N Engl J Med Date: 2016-03-04 Impact factor: 91.245
Authors: Justin Lessler; Cassandra T Ott; Andrea C Carcelen; Jacob M Konikoff; Joe Williamson; Qifang Bi; Lauren M Kucirka; Derek At Cummings; Nicholas G Reich; Lelia H Chaisson Journal: Bull World Health Organ Date: 2016-11-01 Impact factor: 9.408
Authors: Patrícia Brasil; Guilherme Amaral Calvet; André Machado Siqueira; Mayumi Wakimoto; Patrícia Carvalho de Sequeira; Aline Nobre; Marcel de Souza Borges Quintana; Marco Cesar Lima de Mendonça; Otilia Lupi; Rogerio Valls de Souza; Carolina Romero; Heruza Zogbi; Clarisse da Silveira Bressan; Simone Sampaio Alves; Ricardo Lourenço-de-Oliveira; Rita Maria Ribeiro Nogueira; Marilia Sá Carvalho; Ana Maria Bispo de Filippis; Thomas Jaenisch Journal: PLoS Negl Trop Dis Date: 2016-04-12
Authors: Irena Tsui; Luiza M Neves; Kristina Adachi; Stephanie L Gaw; Jose Paulo Pereira; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira; Andrea A Zin Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2019-12-01 Impact factor: 1.300
Authors: Matthew G Zimmerman; Kendra M Quicke; Justin T O'Neal; Nitin Arora; Deepa Machiah; Lalita Priyamvada; Robert C Kauffman; Emery Register; Oluwaseyi Adekunle; Dominika Swieboda; Erica L Johnson; Sarah Cordes; Lisa Haddad; Rana Chakraborty; Carolyn B Coyne; Jens Wrammert; Mehul S Suthar Journal: Cell Host Microbe Date: 2018-11-14 Impact factor: 21.023
Authors: Julia A Brown; Gursewak Singh; Joshua A Acklin; Silviana Lee; James E Duehr; Anupa N Chokola; Justin J Frere; Kevin W Hoffman; Gregory A Foster; David Krysztof; Richard Cadagan; Adam R Jacobs; Susan L Stramer; Florian Krammer; Adolfo García-Sastre; Jean K Lim Journal: Immunity Date: 2019-02-05 Impact factor: 31.745
Authors: Andrea A Zin; Irena Tsui; Julia D Rossetto; Stephanie L Gaw; Luiza M Neves; Olivia A Zin; Lorena Haefeli; Joel Carlos Barros Silveira Filho; Kristina Adachi; Marcos Vinicius da Silva Pone; Sheila Moura Pone; Natalia Molleri; Jose Paulo Pereira; Rubens Belfort; Vaithilingaraja Arumugaswami; Zilton Vasconcelos; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira Journal: J AAPOS Date: 2018-10-22 Impact factor: 1.220
Authors: Leah C Katzelnick; César Narvaez; Sonia Arguello; Brenda Lopez Mercado; Damaris Collado; Oscarlett Ampie; Douglas Elizondo; Tatiana Miranda; Fausto Bustos Carillo; Juan Carlos Mercado; Krista Latta; Amy Schiller; Bruno Segovia-Chumbez; Sergio Ojeda; Nery Sanchez; Miguel Plazaola; Josefina Coloma; M Elizabeth Halloran; Lakshmanane Premkumar; Aubree Gordon; Federico Narvaez; Aravinda M de Silva; Guillermina Kuan; Angel Balmaseda; Eva Harris Journal: Science Date: 2020-08-28 Impact factor: 47.728
Authors: Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans Journal: Clin Microbiol Rev Date: 2019-12-11 Impact factor: 26.132